Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs

被引:1
|
作者
Bonnett, Laura J. [1 ]
Hutton, Jane L. [2 ]
Marson, Anthony G. [3 ,4 ,5 ]
机构
[1] Univ Liverpool, Dept Biostat, Waterhouse Bldg,Block F,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England
[2] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England
[3] Univ Liverpool, Univ Hosp Aintree, Ctr Clin Sci, Dept Mol & Clin Pharmacol, Liverpool L9 7LJ, Merseyside, England
[4] Walton Ctr NHS Fdn Trust, Lower Lane, Liverpool, Merseyside, England
[5] Liverpool Hlth Partners, Lower Lane, Liverpool, Merseyside, England
关键词
Cox model; PWP-TT; Negative binomial; Epilepsy; Seizures; FRACTIONAL POLYNOMIALS; TREATMENT FAILURE; EPILEPSY; REGRESSION; RISK; REMISSION; SANAD; LAMOTRIGINE; TOPIRAMATE;
D O I
10.1186/s12874-020-00965-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Predictive models within epilepsy are frequently developed via Cox's proportional hazards models. These models estimate risk of a specified event such as 12-month remission. They are relatively simple to produce, have familiar output, and are useful to answer questions about short-term prognosis. However, the Cox model only considers time to first event rather than all seizures after starting treatment for example. This makes assessing change in seizure rates over time difficult. Variants to the Cox model exist enabling recurrent events to be modelled. One such variant is the Prentice, Williams and Peterson - Total Time (PWP-TT) model. An alternative is the negative binomial model for event counts. This study aims to demonstrate the differences between the three approaches, and to consider the benefits of the PWP-TT approach for assessing change in seizure rates over time. Methods Time to 12-month remission and time to first seizure after randomisation were modelled using the Cox model. Risk of seizure recurrence was modelled using the PWP-TT model, including all seizures across the whole follow-up period. Seizure counts were modelled using negative binomial regression. Differences between the approaches were demonstrated using participants recruited to the UK-based multi-centre Standard versus New Antiepileptic Drug (SANAD) study. Results Results from the PWP-TT model were similar to those from the conventional Cox and negative binomial models. In general, the direction of effect was consistent although the variables included in the models and the significance of the predictors varied. The confidence intervals obtained via the PWP-TT model tended to be narrower due to the increase in statistical power of the model. Conclusions The Cox model is useful for determining the initial response to treatment and potentially informing when the next intervention may be required. The negative binomial model is useful for modelling event counts. The PWP-TT model extends the Cox model to all included events. This is useful in determining the longer-term effects of treatment policy. Such a model should be considered when designing future clinical trials in medical conditions typified by recurrent events to improve efficiency and statistical power as well as providing evidence regarding changes in event rates over time.
引用
收藏
页数:14
相关论文
共 27 条
  • [1] Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs
    Laura J. Bonnett
    Jane L. Hutton
    Anthony G. Marson
    BMC Medical Research Methodology, 20
  • [2] Measuring outcomes of treatment with antiepileptic drugs in clinical trials
    Ben-Menachem, Elinor
    Sander, Josemir W.
    Privitera, Michael
    Gilliam, Frank
    EPILEPSY & BEHAVIOR, 2010, 18 (1-2) : 24 - 30
  • [3] New antiepileptic drugs: Comparison of key clinical trials
    Cramer, JA
    Fisher, R
    Ben-Menachem, E
    French, J
    Mattson, RH
    EPILEPSIA, 1999, 40 (05) : 590 - 600
  • [4] Should Antiepileptic Drugs Be Initiated in the Emergency Department After a First-Time Seizure?
    Brown, Michael
    Carlson, Jestin N.
    Jones, Alan
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (06) : 752 - 754
  • [5] Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions
    Friedman, Daniel
    French, Jacqueline A.
    LANCET NEUROLOGY, 2012, 11 (09) : 827 - 834
  • [7] CLINICAL-TRIALS OF INVESTIGATIONAL ANTIEPILEPTIC DRUGS - MONOTHERAPY DESIGNS
    PLEDGER, GW
    KRAMER, LD
    EPILEPSIA, 1991, 32 (05) : 716 - 721
  • [8] Designing Clinical Trials to Assess Antiepileptic Drugs as MonotherapyDifficulties and Solutions
    Emilio Perucca
    CNS Drugs, 2008, 22 : 917 - 938
  • [9] When clinical trials make history: Demonstrating efficacy of new antiepileptic drugs as monotherapy
    Perucca, Emilio
    EPILEPSIA, 2010, 51 (10) : 1933 - 1935
  • [10] A Systematic Review of Seizure-Freedom Rates in Patients With Benign Epilepsy of Childhood With Centrotemporal Spikes Receiving Antiepileptic Drugs
    Gerstl, Lucia
    Willimsky, Eva
    Remi, Constanze
    Noachtar, Soheyl
    Borggraefe, Ingo
    Tacke, Moritz
    CLINICAL NEUROPHARMACOLOGY, 2021, 44 (02) : 39 - 46